-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
WHO WE HELP
-
Pharmaceutical Manufacturers
-
Emerging Biopharma
-
MedTech
-
Financial Institutions
-
Government and Public Health
-
Health Plans
-
Hospital and Health Systems
-
Insurers and Risk
-
Medical Specialty and Patient Advocacy
Pharmaceutical Manufacturers
Harness unparalleled healthcare data, advanced analytics, and cutting-edge technologies with our expertise to accelerate the development and commercialization of innovative medicines, enhancing patient lives.
Discover MorePharmaceutical Manufacturers
Emerging Biopharma (Global page)
Boost your innovation with IQVIA's expert team. Our comprehensive solutions integrate top-tier insights, technology, and expertise to maximize your asset's success in a competitive landscape.
Discover InnovationsMedTech
Navigating MedTech's unique landscape: U.S. decision-making now rests with GPOs, IDNs, and payers, who demand solid value proof through rigorous outcomes analyses and pricing scrutiny.
Explore MedTechMedTech
Financial Institutions
Invest in healthcare with confidence. Stay ahead of pharma and medical device trends using real-time, high-quality data. Access market insights, historical sales, prescription trends, and emerging product information for informed, risk-reduced decisions.
Access InsightsGovernment and Public Health
Unlock deeper health insights with unmatched data and innovative technology to enhance decision-making for your essential government programs.
Unlock InnovationsGovernment and Public Health
Health Plans
Accelerate digital innovation with our data-driven expertise in data science and healthcare, optimizing business processes for smarter decisions.
Navigate Health PlansHospital and Health Systems
Leverage digital innovation to cut costs, boost efficiency, and elevate patient engagement, all while enhancing quality and health outcomes.
Streamline DecisionsHospital and Health Systems
Insurers and Risk
Enhance your ability to evaluate and forecast population risk swiftly and accurately by integrating unmatched data, expertise, and technology.
Uncover More
Medical Specialty and Patient Advocacy
Transform into a data-driven organization that enhances your specialty and showcases value to your members through digital transformation.
Explore NowU.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREBLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS
PODCASTS
"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTS
Blog
Enhancing Pharmaceutical Marketing: Proven Strategies for Engaging Healthcare Providers
Mar 07, 2023
In today's complex and rapidly evolving healthcare landscape, reaching and engaging healthcare providers (HCPs) has become a major challenge for the pharmaceutical industry. With a growing demand for personalized and seamless experiences, pharma companies are faced with the task of creating meaningful and impactful interactions with HCPs. To achieve this, the industry must adopt effective marketing strategies that are tailored to the unique needs and preferences of HCPs.
The pharmaceutical industry can take a data-driven, multi-channel, patient-centric, and educational approach to reach healthcare providers and build strong, collaborative relationships. By understanding the unique needs and preferences of HCPs, the industry can create more personalized and impactful marketing efforts, resulting in better outcomes for both HCPs and patients.
Understanding HCPs
HCPs are busy individuals who are inundated with information from a variety of sources. They depend on reliable and trustworthy sources to stay informed about the latest developments in their field and make decisions that impact their patients. To effectively reach and engage HCPs, it is crucial to understand their unique needs, preferences, and behaviors.
According to a recent study, 89% of HCPs prefer personalized interactions with pharmaceutical companies. HCPs value education and opportunities to stay up to date on the latest developments in their field, with 94% believing it is important for pharmaceutical companies to work with them to address their challenges and concerns. Additionally, 63% of HCPs use social media to access information related to their field, while 60% prefer to receive information from pharmaceutical companies through email.
Ways to More Effectively Market to HCPs
Data-Driven Approach
Utilizing data and analytics is key to creating targeted and personalized marketing efforts that resonate with HCPs. By gaining insights into HCP preferences, behaviors, and needs, the pharmaceutical industry can reach HCPs in a way that is tailored to their specific needs and preferences. This data-driven approach makes interactions with HCPs more meaningful and impactful.
By utilizing data, pharmaceutical companies can analyze individual healthcare providers' preferences, behaviors, and prescribing patterns at scale. For example, they can identify which healthcare providers have a preference for a specific channel, patient demographics, and clinical characteristics. This enables companies to generate personalized recommendations for sales representatives to engage with each provider in a personalized manner delivering to them the most relevant clinical trial data, educational resources, or patient materials. By providing personalized and relevant information, they can increase the likelihood of successful sales conversations, improve healthcare providers' perceptions of their brand, and ultimately drive revenue growth.
Multi-Channel Marketing
HCPs use a variety of channels to access information and communicate with others in their field. By utilizing a multi-channel approach to marketing, the pharmaceutical industry can reach HCPs through their preferred channels and increase the likelihood of engagement as a first step. In addition, by leveraging artificial intelligence and machine learning to analyze large amounts of data, pharmaceutical companies can improve delivering the optimal sequence of channel engagement, driving better outcomes and ultimately improving patient care.
Patient-Centric Focus
HCPs make decisions based on what is best for their patients. By placing a patient-centric focus on marketing efforts and highlighting how a product or service can improve patient outcomes, the pharmaceutical industry can more effectively engage HCPs. This patient-centric approach also helps build trust and establish the pharma company as a valued partner in the HCP's efforts to improve patient outcomes.
Pharmaceutical companies can identify medically relevant patients who could benefit from their therapies but have not yet tried them. Then they can use this information to target the healthcare providers to follow up with those patients. By starting with this foundation, companies can then leverage AI/ML solutions to suggest the most effective way to engage those healthcare providers and successfully start patients on their therapies.
Education and Thought Leadership
Providing educational resources and thought leadership content is crucial for establishing the pharmaceutical industry as a trusted and valuable resource for HCPs. This helps build trust and establish the pharma company as a knowledgeable and credible partner.
Collaborative Relationships
Building collaborative relationships with HCPs is key to more effectively marketing to them. This requires the pharmaceutical industry to listen to HCPs' needs and preferences, and work with them to address their challenges and concerns. By collaborating with HCPs, the industry can create solutions that are tailored to their needs and help build trust and credibility.
Collaborative relationships are essential for building trust and credibility with HCPs. By staying ahead of the curve and taking a proactive approach to marketing, the industry can continue to build strong and impactful relationships with HCPs.
IQVIA Next Best – Recommendations Platform
Precision intelligence that targets effectively via the right channels at the right time to drive your HCP messages home.
Related solutions
Field Force Operations
Keep your field force focused and productive